Experts debate when to initiate ART in asymptomatic HIV

Experts debate when to initiate ART in asymptomatic HIV

No trial has demonstrated net benefit from use of ART above currently accepted CD4 count thresholds (350 cells/mcL), and the completed observation studies do not support the claim of benefit either, according to Lundgren, who added that there are also no data to support early ART in resource-limited...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Infectious Disease News 2012-12, Vol.25 (12), p.20
Hauptverfasser: Henry, Jennifer, Kalvaitis, Katie
Format: Artikel
Sprache:eng
Schlagworte:
Acquired immune deficiency syndrome
AIDS
Colleges & universities
Debates
HIV
Human immunodeficiency virus
Patients
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:No trial has demonstrated net benefit from use of ART above currently accepted CD4 count thresholds (350 cells/mcL), and the completed observation studies do not support the claim of benefit either, according to Lundgren, who added that there are also no data to support early ART in resource-limited settings.
ISSN:1056-9251